怪物饮料 MNST 深 沪
已收盘 08-29 16:00:00 美东时间
62.41
+0.390
+0.63%
华盛通- 最 高62.53
- 今 开61.93
- 成交量 416.45万股
- 最 低 61.76
- 昨 收 62.02
- 总市值 608.50亿
- 52周最高 66.75
- 市盈率 静 41.90
- 换手率 0.43%
- 52周最低 45.70
- 委 比 -46.63%
- 总股本 9.75亿
- 历史最高 66.75
- 量 比 0.82
- 振 幅 1.24%
- 历史最低 5.7383
- 每 手 1
- 风险率 5.12%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多“咖啡因经济”热潮消退！Keurig Dr Pepper(KDP.US)豪掷180亿拆解饮料帝国 迎合资本“单品”偏好
Keurig Dr Pepper似乎正在推行一项专注于核心业务的战略，以扭转此前企业合并后成效不彰的局面。
08-26 21:09
“胡椒博士”喝下“皮爷咖啡”：美饮料巨头180亿豪赌咖啡霸权
①美国饮料巨头Keurig Dr Pepper宣布将以全现金交易方式收购荷兰JDE Peet's，交易价值约合180亿美元；②收购完成后，KDP计划分拆为两家独立上市公司，一家主攻北美饮料市场，另一家专注全球纯咖啡业务。
08-25 18:45
Peering Into Monster Beverage's Recent Short Interest
Monster Beverage's (NYSE:MNST) short percent of float has fallen 11.92% since i...
08-16 04:00
美股大行评级 | 潜在涨幅95.33%！HC Wainwright & Co.上调Insmed目标价至240美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Insmed"买入"评级，目标价从120美元升至240美元；巴克莱：维持Transocean"超配"评级，目标价从3.5美元升至4美元
08-14 09:25
Milestone Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Regulatory and Corporate Update
Milestone Pharmaceuticals reported its second-quarter 2025 financial results and updates, noting the FDA accepted the company's response to the CRL for CARDAMYST™ (etripamil) nasal spray, setting a new PDUFA target date of December 13, 2025. The company completed a public offering, raising up to $170 million, and extended a $75 million royalty agreement with RTW through December 2025. Financials showed cash of $43.4 million as of June 30, 2025, a...
08-12 11:05
美股大行评级 | 潜在涨幅286.44%！RBC Capital上调Edgewise Therapeutics目标价至49美元，维持"跑赢大市"评级
今日重点评级关注：RBC Capital：维持Edgewise Therapeutics"跑赢大市"评级，目标价从48美元升至49美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从6美元升至7美元
08-11 09:43
IonQ, Eli Lilly, Monster, Crocs, Kratos Trending by Analysts
Analysts are intrested in these 5 stocks: ( ($IONQ) ), ( ($LLY) ), ( ($MNST) ),...
08-09 17:02
尾盘：道指上涨逾200点 纳指上涨1%
北京时间8月9日凌晨，美股周五尾盘维持涨势，道指上涨逾200点，纳指上涨1%。本周三大股指均有望录得涨幅。市场继续关注美股财报、特朗普关税与美联储高层人事变...
08-09 02:53
D-Wave Quantum's Cash Hoard Fuels Aggressive Expansion
D-Wave's strongest-ever cash position is funding acquisitions, technology development and manufacturing expansion while its system sales pipeline has doubled, even as the company remains EBITDA-negative.
08-09 02:12
Tech Stocks Eye Record Highs As Magnificent Seven Top $19.5 Trillion: What's Moving Markets Friday?
Tech stocks staged a full rebound from last Friday's sell-off, with the Nasdaq 100 surging to 23,600 — just shy of the 23,700 all-time high set in late July, as the week’s strong sector earnings and broad gains among the Magnificent Seven fueled the rally.
08-09 01:25
